Dalyong Kim

544 total citations
27 papers, 304 citations indexed

About

Dalyong Kim is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dalyong Kim has authored 27 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dalyong Kim's work include Colorectal Cancer Treatments and Studies (4 papers), Patient Dignity and Privacy (3 papers) and Palliative Care and End-of-Life Issues (3 papers). Dalyong Kim is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Patient Dignity and Privacy (3 papers) and Palliative Care and End-of-Life Issues (3 papers). Dalyong Kim collaborates with scholars based in South Korea and Puerto Rico. Dalyong Kim's co-authors include Y.-H. Kim, Yong‐Hee Kim, Jae‐Lyun Lee, Yong Sang Hong, Yong‐Soon Kwon, Bhumsuk Keam, Jihun Kim, Inkeun Park, Miso Kim and Yeonjoo Choi and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Cancers.

In The Last Decade

Dalyong Kim

22 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dalyong Kim South Korea	9	102	92	65	55	43	27	304
Jacques Cretin France	7	57 0.6×	171 1.9×	86 1.3×	44 0.8×	41 1.0×	9	328
Hayriye Tatlı Doğan Türkiye	11	82 0.8×	107 1.2×	81 1.2×	101 1.8×	32 0.7×	41	338
Anna Castiglione Italy	12	76 0.7×	65 0.7×	94 1.4×	63 1.1×	38 0.9×	19	366
Jochen Wilke Germany	8	72 0.7×	98 1.1×	30 0.5×	56 1.0×	28 0.7×	21	265
N. Tsavaris Greece	10	70 0.7×	196 2.1×	63 1.0×	34 0.6×	48 1.1×	38	324
Andrea Wahner Hendrickson United States	8	32 0.3×	146 1.6×	64 1.0×	79 1.4×	27 0.6×	17	293
Jean Torrisi United States	7	67 0.7×	122 1.3×	91 1.4×	72 1.3×	25 0.6×	11	307
Vijai Simha India	9	80 0.8×	87 0.9×	93 1.4×	27 0.5×	22 0.5×	24	216
A. Milner Australia	11	154 1.5×	141 1.5×	145 2.2×	44 0.8×	46 1.1×	24	398
Alfred Guirguis United States	9	64 0.6×	68 0.7×	41 0.6×	53 1.0×	17 0.4×	12	213

Countries citing papers authored by Dalyong Kim

Since Specialization

Citations

This map shows the geographic impact of Dalyong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalyong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalyong Kim more than expected).

Fields of papers citing papers by Dalyong Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalyong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalyong Kim. The network helps show where Dalyong Kim may publish in the future.

Co-authorship network of co-authors of Dalyong Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Dalyong Kim. A scholar is included among the top collaborators of Dalyong Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalyong Kim. Dalyong Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Yeon Wook, et al.. (2025). Validation of Sybil Deep Learning Lung Cancer Risk Prediction Model in Asian High- and Low-risk Individuals. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5012–A5012.

Park, Seong Yeon, et al.. (2025). Pneumocystis jirovecii pneumonia in patients with lung cancer receiving immune checkpoint inhibitors: a retrospective nationwide population-based cohort study from South Korea. Discover Oncology. 16(1). 950–950.

Shin, Sung Joon, et al.. (2024). Navigating shared decision-making after the Life-Sustaining Treatment Decision Act: a qualitative study of in-depth interviews with terminal cancer patients, families, and healthcare professionals. Supportive Care in Cancer. 32(12). 796–796. 1 indexed citations

Park, Seong Yeon, et al.. (2024). Reactivation of Varicella-Zoster Virus in Patients with Lung Cancer Receiving Immune Checkpoint Inhibitors: Retrospective Nationwide Population-Based Cohort Study from South Korea. Cancers. 16(8). 1499–1499. 1 indexed citations

Lee, Kyeong, Young‐Ah Suh, Dalyong Kim, et al.. (2022). BAP1 Downregulates NRF2 Target Genes and Exerts Anti-Tumorigenic Effects by Deubiquitinating KEAP1 in Lung Adenocarcinoma. Antioxidants. 11(1). 114–114. 8 indexed citations

Kim, Dalyong, et al.. (2021). Consistent Response on Challenge and Rechallenge of Liposomal Irinotecan in a Patient with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine plus Nab-Paclitaxel: A Case Report. Case Reports in Oncology. 14(3). 1882–1888.

Kim, Dalyong, Soo Hyun Lee, Taemi Youk, & Soojung Hong. (2021). Incidence and Clinical Outcomes of Febrile Neutropenia in Adult Cancer Patients with Chemotherapy Using Korean Nationwide Health Insurance Database. Yonsei Medical Journal. 62(6). 479–479. 2 indexed citations

Kim, Dalyong, Jung Hye Kwon, Hee Kyung Ahn, et al.. (2021). Awareness of Doctors’ Shared Decision-Making in Life-Sustaining Care Decisions. The Korean Journal of Hospice and Palliative Care. 24(4). 204–213. 5 indexed citations

Kim, Dalyong, Shin Hye Yoo, Seyoung Seo, et al.. (2021). Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea. Cancer Research and Treatment. 54(1). 20–29. 11 indexed citations

10.

Kim, Dalyong, et al.. (2020). The efficacy and safety of onartuzumab in patients with solid cancers: A meta-analysis of randomized trials. Indian Journal of Cancer. 58(2). 232–232. 5 indexed citations

11.

Choi, Yeonjoo, Bhumsuk Keam, Miso Kim, et al.. (2019). Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients. Cancer Research and Treatment. 51(4). 1549–1556. 39 indexed citations

12.

Jeong, Jae Ho, Jihun Kim, Yong Sang Hong, et al.. (2017). HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF. Clinical Colorectal Cancer. 16(3). e147–e152. 33 indexed citations

13.

Kim, Dalyong, Sun Young Kim, Ji Sung Lee, et al.. (2017). Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer. BMC Gastroenterology. 17(1). 121–121. 12 indexed citations

14.

Kim, Dalyong, Yong Sang Hong, Jeong Eun Kim, et al.. (2016). Use of a High-Throughput Genotyping Platform (OncoMap) for <i>RAS</i> Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer. Cancer Research and Treatment. 49(1). 37–43. 3 indexed citations

15.

Park, Jin‐hong, Dok Hyun Yoon, Dalyong Kim, et al.. (2014). The highest prognostic impact of LDH among International Prognostic Indices (IPIs): an explorative study of five IPI factors among patients with DLBCL in the era of rituximab. Annals of Hematology. 93(10). 1755–1764. 32 indexed citations

16.

Kim, Kang‐Il, et al.. (2010). Radioisotope synoviorthesis with Holmium‐166‐chitosan complex in haemophilic arthropathy. Haemophilia. 16(4). 640–646. 24 indexed citations

17.

Han, Ae Ra, Yong‐Soon Kwon, Dalyong Kim, et al.. (2009). Pregnancy Outcomes Using Assisted Reproductive Technology After Fertility-Preserving Therapy in Patients With Endometrial Adenocarcinoma or Atypical Complex Hyperplasia. International Journal of Gynecological Cancer. 19(1). 147–151. 29 indexed citations

18.

Pak, Jhang Ho, Won‐Ho Choi, J. Y. Kim, et al.. (2007). Detection of ovarian cancer-specific gene by differentially expressed gene polymerase chain reaction prescreening and direct DNA sequencing. Journal of Clinical Oncology. 25(18_suppl). 21106–21106. 3 indexed citations

19.

Joo, Won Duk, Dalyong Kim, Jin Hyoung Kim, et al.. (2004). 851 Prevalence of Human Papillomavirus Infection in Korean Women: Risks of Abnormal Pap Smear and Cervical Neoplasia. International Journal of Gynecological Cancer. 14. 234–234. 1 indexed citations

20.

Im, Sun, et al.. (2004). Expression of cyclooxygenase-2 in Korean breast cancer patients and the in vitro growth inhibitory effect of celecoxib in breast cancer cells. Journal of Clinical Oncology. 22(14_suppl). 9715–9715. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact